Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: June 29, 2016

Man-made breast milklike sugar shown to treat lung damage in mice

Johns Hopkins researchers report they have figured out a root cause of the lung damage that occurs in up to 10 percent of premature infants who develop necrotizing enterocolitis, a disorder that damages and kills the lining of the intestine.

Released: June 27, 2016

Study points to potential of drug target

Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson’s disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder’s presence and progression.

Released: June 27, 2016

Johns Hopkins researchers find that the bacteria in our mouths could be a tool for finding and fighting cancer

In a sample study, researchers at Johns Hopkins say they have found an association between the makeup of an individual’s microbiome and head and neck cancer, a finding that potentially advances the quest for faster and more accurate cancer diagnosis and therapy.

Released: June 27, 2016

Emetime appears to stop replication of a herpesvirus

Researchers at Johns Hopkins have found that an old drug once mostly used to treat amebiasis — a disease caused by a parasite — and induce vomiting in cases of poisoning appears to also halt replication of cytomegalovirus (CMV), a herpesvirus that can cause serious disease in immunocompromised individuals, including those with HIV or organ transplant recipients.

Released: June 27, 2016

Using so-called next-generation genome sequencing, researchers at Johns Hopkins have identified 84 potential inherited gene mutations that may contribute to the most severe forms of bipolar disorder. About 5.6 million Americans are estimated to have bipolar disorder.

Released: June 23, 2016

What will it take to move cancer research forward? That’s the focus of a summit convened by Vice President Joe Biden at Howard University in Washington, D.C., on June 29. The gathering will include patients, cancer clinicians, scientists, industry leaders and others to discuss topics including how to accelerate the pace of cancer research discoveries and data sharing, improve access to care, remove regulatory barriers, and foster collaboration among scientists and industry partners. 

Released: June 23, 2016

Review of case reports uncovers rheumatologic disease in 13 patients taking checkpoint inhibitors

Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a preliminary study by Johns Hopkins Medicine researchers. 

Released: June 22, 2016

Pioneering Public-Private Cancer Initiative with Unified Leadership Committed to Changing the Course of Cancer Care

Released: June 21, 2016

In a proof-of-principle study, a team of physicians and bioinformatics experts at Johns Hopkins reports they were able to diagnose or rule out suspected brain infections using so called next-generation genetic sequencing of brain tissue samples.

Released: June 20, 2016

Levels of a growth factor rise predict survival, study shows

Johns Hopkins Medicine researchers report that rising blood levels of a protein called hematoma derived growth factor (HDGF) are linked to the increasing severity of pulmonary arterial hypertension, a form of damaging high blood pressure in the lungs.

Released: June 20, 2016

Small study shows some on opioids reported more pain, fatigue

In a small study looking at pain assessments in adults with sickle cell disease, researchers at Johns Hopkins says overall, those treated long-term with opioids often fared worse in measures of pain, fatigue and curtailed daily activities than those not on long-term opioids.

Released: June 16, 2016

Study in mice teases out important role of the liver in balancing fats and sugars

Sugar in the form of blood glucose provides essential energy for cells. When its usual dietary source — carbohydrates — is scarce, the liver can produce it with the aid of fat. But new research from Johns Hopkins now adds to evidence that other tissues can step in to make glucose when the liver’s ability is impaired, and that the breakdown of fats in the liver is essential to protect it from a lethal onslaught of fat. The new research findings, from studies in mice, are likely to help researchers better understand a growing class of often-deadly metabolic diseases, which affect how the body processes nutrients, the investigators say.

Released: June 16, 2016

Cells grown from pluripotent stem cells connect to and control heart muscle cells

Researchers at Johns Hopkins report that a type of lab-grown human nerve cells can partner with heart muscle cells to stimulate contractions. Because the heart-thumping nerve cells were derived from induced pluripotent stem cells that in turn were made from human skin cells, the researchers believe the cells — known as sympathetic nerve cells — will be an aid in studying disorders that affect the nervous system — that is, scientists will be able to grow nerve cells in the lab that replicate particular patients’ diseases. 

Released: June 16, 2016

A Johns Hopkins University School of Medicine study of insurance coverage of more than 28,000 people with HIV concludes that a decades-old program that offers free medical care remains a critical necessity despite the availability of coverage under the Affordable Care Act (ACA).

Released: June 14, 2016

In the wake of a tragic event like the massacre that occurred in Orlando last weekend, parents are often faced with a challenge: What, how and how much should they tell their children?

Children have nearly impeccable radars for parental anxiety, a condition that can have a trickle-down effect. In the aftermath of a stressful event — whether it’s a natural disaster, a shooting or public unrest — children can feel confused, frightened and upset. 

Released: June 14, 2016

Tina Cheng, M.D., M.P.H., has been named the Given Foundation Professor of Pediatrics, director of the Department of Pediatrics for the Johns Hopkins University School of Medicine and pediatrician-in-chief of The Johns Hopkins Hospital.

Released: June 9, 2016

Lab test may predict glioblastoma aggression and spread

Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the “speed” of human brain tumor cell movement along a small glass “track.” The assay, so far tested on the cells of 14 glioblastoma patients, has the potential, they say, to predict how quickly and aggressively a given cancer might lethally spread.

Released: June 8, 2016

In an effort to identify a simple, reliable way to track the course of nasal polyps in chronic sinus disease, Johns Hopkins Medicine researchers say they’ve linked rising levels of immune system white blood cells, called eosinophils, with regrowth of polyps removed by surgery.

Released: June 8, 2016

Patient Discharge Summary Delays Can Lead to Readmissions

A team of Johns Hopkins clinicians and researchers today published a study linking the length of time it takes a physician to complete a patient’s discharge report with the risk of that patient’s readmission to the hospital.

Released: June 2, 2016

Guidelines to keep people protected during the upcoming months

It’s that time of year again where the living is a little more carefree and many are taking advantage of the warmer weather. But with more outdoor activities, there tend to be more dangers. Whether it be the sun or pesky insect bites, our experts have some tips on how to stay safe outside and keep the fun all summer long.